Placebo for petrelintide clinical trials

A randomized, double-blind, Phase 2, dose-finding trial of once weekly petrelintide compared with placebo in participants with obesity or overweight with weight related comorbidities

This study is testing a new weekly medicine, petrelintide, for people who are overweight or have obesity and related health problems. Researchers want to see how well it helps with weight loss compared to a dummy treatment.